Distinct subtypes of Alzheimer’s disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications
暂无分享,去创建一个
Lena Cavallin | Andrew Simmons | J-Sebastian Muehlboeck | Eric Westman | Juan Andrés Hernández-Cabrera | Lars-Olof Wahlund | Daniel Ferreira | A. Simmons | E. Westman | J. Muehlboeck | L. Wahlund | D. Ferreira | U. Ekman | J. Barroso | L. Cavallin | C. Verhagen | J. Hernández-Cabrera | Chunjie Guo | Chloë Verhagen | Chun-Jie Guo | Urban Ekman | José Barroso | J.-Sebastian Muehlboeck
[1] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[2] R. Keren,et al. An exploration of cognitive subgroups in Alzheimer’s disease , 2009, Journal of the International Neuropsychological Society.
[3] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[4] Y. Benjamini,et al. More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.
[5] F Barkhof,et al. Qualitative Assessment of Cerebral Atrophy on MRI: Inter- and Intra-Observer Reproducibility in Dementia and Normal Aging , 1997, European Neurology.
[6] Nick C Fox,et al. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele , 2011, The Lancet Neurology.
[7] P. Scheltens,et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[8] R. Reitan. Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .
[9] Nick C Fox,et al. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases , 2016, Brain : a journal of neurology.
[10] Medial temporal lobe atrophy scores translated to clinical practice: Editorial comment on ‘Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut‐offs' , 2014, Journal of internal medicine.
[11] E. Kaplan,et al. The assessment of aphasia and related disorders , 1972 .
[12] Nick C Fox,et al. Revising the definition of Alzheimer's disease: a new lexicon , 2010, The Lancet Neurology.
[13] G. Chelune,et al. Education-stratified base-rate information on discrepancy scores within and between the Wechsler Adult Intelligence Scale--Third Edition and the Wechsler Memory Scale--Third Edition. , 2004, Psychological assessment.
[14] E. Westman,et al. Different reserve proxies confer overlapping and unique endurance to cortical thinning in healthy middle-aged adults , 2016, Behavioural Brain Research.
[15] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[16] Julie S. Snowden,et al. Variability in cognitive presentation of Alzheimer's disease , 2008, Cortex.
[17] J. Yesavage,et al. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. , 1986 .
[18] A. Simmons,et al. Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations , 2015, Neurodegenerative Diseases.
[19] C. Jack,et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study , 2012, The Lancet Neurology.
[20] E. Westman,et al. Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors. , 2016, Journal of Alzheimer's disease : JAD.
[21] C. Jack,et al. Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis , 2011, Neurobiology of Aging.
[22] M. Masellis,et al. White matter hyperintensity burden in elderly cohort studies: The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging Initiative, and Three-City Study , 2016, Alzheimer's & Dementia.
[23] E. Westman,et al. Cognitive decline is mediated by gray matter changes during middle age , 2014, Neurobiology of Aging.
[24] R. Petersen,et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.
[25] Sang Won Seo,et al. Anatomical heterogeneity of Alzheimer disease , 2014, Neurology.
[26] Mike P. Wattjes,et al. Visual assessment of posterior atrophy development of a MRI rating scale , 2011, European Radiology.
[27] Dong Young Lee,et al. Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer’s Disease , 2015, PloS one.
[28] G. Kovacs. Clinical stratification of subtypes of Alzheimer's disease , 2012, The Lancet Neurology.
[29] T. Kurosaki,et al. Measurement of functional activities in older adults in the community. , 1982, Journal of gerontology.
[30] Christos Davatzikos,et al. HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework , 2017, NeuroImage.
[31] Eric Westman,et al. TheHiveDB image data management and analysis framework , 2014, Front. Neuroinform..
[32] W. Vach,et al. Subgroups of Alzheimer's disease: stability of empirical clusters over time. , 2014, Journal of Alzheimer's disease : JAD.
[33] A. Simmons,et al. Practical cut‐offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment , 2015, Journal of internal medicine.
[34] Y. Hong,et al. Prediction of Alzheimer’s disease pathophysiology based on cortical thickness patterns , 2015, Alzheimer's & Dementia.
[35] Nick C Fox,et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.
[36] H. Soininen,et al. Harmonized diagnostic criteria for Alzheimer's disease: recommendations , 2014, Journal of internal medicine.
[37] Frederik Barkhof,et al. Optimizing patient care and research: the Amsterdam Dementia Cohort. , 2014, Journal of Alzheimer's disease : JAD.
[38] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[39] Frank O. Gehry,et al. Lou Ruvo Center for Brain Health , 2010 .
[40] Magda Tsolaki,et al. Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition , 2016, European Radiology.
[41] E. Westman,et al. Electroencephalography Is a Good Complement to Currently Established Dementia Biomarkers , 2016, Dementia and Geriatric Cognitive Disorders.
[42] Masayuki Matsuda,et al. Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease , 2006, NeuroImage.
[43] J Marshall,et al. Cerebral blood flow in dementia. , 1975, Archives of neurology.
[44] Frederik Barkhof,et al. The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[45] C. Jack,et al. Alzheimer's Disease Neuroimaging Initiative , 2008 .